Incidence, Progression and Determinants of Diabetic Retinopathy in Type 2 Diabetes in Australasia: A Systematic...

Current evidence on incidence and progression rate of diabetic retinopathy reveals disparities across Australasia, and no pooled estimates are available to guide region-wide planning. This review and meta-analysis assesses the overall incidence, determinants and progression of diabetic retinopathy in Australasia.

This systematic review followed the Joanna Briggs Institute manual for incidence synthesis. Articles were sourced from Ovid MEDLINE, Scopus, Web of Science, CINAHL, ProQuest and PsycINFO until October 2024. Articles reporting incidence, progression, and determinants of type 2 diabetes in Australia and surrounding islands were included.

Nine cohorts, including seven population-based and two institution-based cohort studies, predominantly from Australia, were analysed. The pooled annual incidence of diabetic retinopathy was 4.22% (95% CI 2.29-6.15), while individual studies reported annual progression from 3.08% to 18.22%. Incident diabetic retinopathy was associated with elevated fasting blood glucose, haemoglobin A1c, systolic blood pressure and increasing connecting peptide levels. Diabetic retinopathy progression was associated with increasing age, higher haemoglobin A1c levels, fasting blood glucose, longer duration of diabetes, an increased albumin-creatinine ratio and no fenofibrate treatment.

Diabetic retinopathy incidence in Australasia is highly variable, highest in institution-based cohorts and among Indigenous Australians. HbA1c is the only determinant consistently and significantly associated with both onset and progression. Because most evidence predates modern diabetes care, future prospective cohorts should adopt standardised, multifactorial designs to generate contemporary, comparable data and reduce persistent inequities in eye-care access.